Resultats de la cerca - Constantinos Pamboukas
- Mostrar 1 - 3 resultats de 3
-
1
A phase 1/2 study of lenalidomide with low-dose oral cyclophosphamide and low-dose dexamethasone (RdC) in AL amyloidosis per Efstathios Kastritis, Evangelos Terpos, Μαρία Ρούσσου, Maria Gavriatopoulou, Constantinos Pamboukas, Ioannis Boletis, Smaragda Marinaki, Theofanis Apostolou, Nikitas Nikitas, Georgios Gkortzolidis, Eurydiki Michalis, Sossana Delimpasi, Meletios Α. Dimopoulos
Publicat 2012Artigo -
2
Treatment of light chain (AL) amyloidosis with the combination of bortezomib and dexamethasone per Efstathios Kastritis, Αchilles Anagnostopoulos, Μαρία Ρούσσου, Savvas Toumanidis, Constantinos Pamboukas, Magdalini Migkou, Anna Tassidou, Irini Xilouri, Sossana Delibasi, Erasmia Psimenou, S. Mellou, Evangelos Terpos, J. Nanas, Meletios Α. Dimopoulos
Publicat 2007Artigo -
3
Cardiac and renal complications of carfilzomib in patients with multiple myeloma per Meletios Α. Dimopoulos, Μαρία Ρούσσου, Maria Gavriatopoulou, Erasmia Psimenou, Dimitrios C. Ziogas, Evangelos Eleutherakis‐Papaiakovou, Despina Fotiou, Magdalini Migkou, Nikolaos Kanellias, Ioannis Panagiotidis, Argyrios Ntalianis, Elektra Papadopoulou, Κimon Stamatelopoulos, Efstathios Manios, Constantinos Pamboukas, Sofoklis Kontogiannis, Evangelos Terpos, Efstathios Kastritis
Publicat 2017Artigo
Eines de cerca:
Matèries relacionades
Internal medicine
Medicine
Multiple myeloma
AL amyloidosis
Amyloidosis
Antibody
Bortezomib
Dexamethasone
Discontinuation
Gastroenterology
Immunoglobulin light chain
Immunology
Surgery
Urology
Carfilzomib
Chemotherapy
Creatinine
Cyclophosphamide
Dialysis
Ejection fraction
Heart failure
Immunopathology
Lenalidomide
Melphalan
Phases of clinical research
Primary systemic amyloidosis
Proteasome inhibitor
Rash
Regimen
Renal function